Jan 6, 2021 · The richest nations have secured billions of doses of COVID-19 vaccines, while developing economies struggle to access supplies. Vaccine nationalism – where countries push to get first access – could slow the global economic recovery, costing high …

Jan 31, 2022 · The large crowds gathered to protest COVID-19 vaccine mandates suggest hesitancy may be more common in Europe than survey results indicate, according to this piece – which traces some of the region’s anti-vaccination history. (Institut Montaigne)

Nov 20, 2020 · Tackling COVID-19 will require the first-ever deployment of blockchain in the global distribution of a vaccine. Blockchain offers an immutable, decentralized database that can help all parties be sure that vaccine supplies are being stored and handled properly.

Jun 8, 2021 · The world will need billions of COVID-19 vaccine doses. Around the world, there is a concerted effort under way to vaccinate as many people as possible against COVID-19, as quickly as possible. After slow starts in some countries, steady progress is now being made - although the rollout remains unequal .

Jul 29, 2021 · The COVID vaccine market is worth at least $150 billion. Can we stop it being flooded with fakes? As recently as 15 years ago, building a facility to produce biologics such as monoclonal antibodies or vaccines could require an investment of as much as €500m, and it would take up to 3 years to bring that facility online.

May 28, 2020 · Organizations are also examining ways to limit the spread of COVID-19, particularly among vulnerable populations. Closedloop, an AI start-up that we work with, is using their expertise in healthcare data to identify those at the highest risk of severe complications from COVID-19. Closedloop has developed and open-sourced a COVID vulnerability ...

Jun 28, 2021 · This makes overcoming COVID-19 vaccine hesitancy, procrastination, and rejection the greatest marketing communication challenge of our lifetime. The US is moving “from a supply problem to a demand problem,” as Dr David Kessler, the chief science officer for the US government’s COVID-19 response task force noted earlier this year.

Jan 13, 2023 · Scientists in November announced a breakthrough in work towards developing a 'universal' flu vaccine.Using the same messenger ribonucleic acid (mRNA) technology that's been used in several COVID-19 vaccines, researchers at the University of Pennsylvania were able to develop a vaccine against all the 20 known influenza A and B virus subtypes.

Aug 3, 2021 · “Vaccine inequity is the world’s biggest obstacle to ending this pandemic and recovering from COVID-19,” Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), said last month.

May 5, 2021 · Results from a study in Israel revealed this week that two doses of the Pfizer/BioNTech vaccine offers 95% efficacy against infection, hospitalization and death from COVID-19. The expectation is that with a vaccine, some aspects of life will return to normal – especially when it comes to travel – which has been particularly hard-hit.